BETHESDA, Md., March 6 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, March 13, 2008, at 9:00 am Eastern Time (2:00 pm Central European Time) to discuss its fourth quarter and full year 2007 financial results. Micromet anticipates releasing its financial results at 7:00 am Eastern Time (12:00 pm Central European Time) on Thursday, March 13, 2008.
To participate in this conference call, dial 800-561-2813 (U.S.) or 617-614-3529 (international), passcode: 29595857. The audio webcast can be accessed at: http://www.micromet-inc.com in the investor relations section of the website.
A replay of the call will be available from 11:00 am Eastern Time on March 13, 2008 (4:00 pm Central European Time) through Thursday, March 20, 2008. The replay number is 888-286-8010 (U.S.) or 617-801-6888 (international), passcode: 40638317.
About Micromet, Inc. (http://www.micromet-inc.com)
Micromet, Inc. is a biopharmaceutical company developing novel,
proprietary antibodies for the treatment of cancer, inflammation and
autoimmune diseases. Three of its antibodies are in clinical development.
MT103 (MEDI-538), the most advanced antibody in Micromet's product pipeline
developed using the BiTE(R) antibody technology platform, is being
developed in a phase 2 clinical trial for the treatment of patients with
acute lymphoblastic leukemia, and in a phase 1 clinical trial for the
treatment of patients with n
|SOURCE Micromet, Inc.|
Copyright©2008 PR Newswire.
All rights reserved